Sign in

CIK 0001401040

  • Non-accelerated filer
  • Smaller reporting company

DiaMedica Therapeutics Inc.

Sign in to watch
Ticker
DMAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Canada (Federal Level)
Entity type
Operating
Phone
+1 763-496-5454
Business address
301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
Former names
DiaMedica Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-01 Semba Charles Pauling Director Grant or award · Stock Option (right to buy) +40,412 40,412
2026-01-02 Semba Charles Pauling Director Grant or award +3,355 $8.42 $28K 47,963
2025-06-01 Semba Charles Pauling Director Grant or award · Stock Option (right to buy) +32,162 32,162
2025-01-02 Semba Charles Pauling Director Grant or award +5,290 $5.34 $28K 44,608
2024-06-01 Semba Charles Pauling Director Grant or award · Stock Option (right to buy) +28,472 28,472
2024-01-02 Semba Charles Pauling Director Grant or award +9,375 $2.80 $26K 39,318
2023-06-23 Semba Charles Pauling Director Purchase +12,787 $3.91 $50K 29,943
2023-06-01 Semba Charles Pauling Director Grant or award · Stock Option (right to buy) +16,968 16,968
2023-01-03 Semba Charles Pauling Director Grant or award +17,156 $1.53 $26K 17,156
2022-06-01 Semba Charles Pauling Director Grant or award · Stock Option (right to buy) +13,222 13,222
2021-07-15 Semba Charles Pauling Director Grant or award · Stock Option (right to buy) +18,786 18,786

Page 1 of 1 · 11 trades